Embla Medical hf (FRA:5IQ) Retained Earnings: €769.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5IQ Embla Medical hf FRA:5IQ
71 GF Score
Price €3.69
GF Value €4.45
Valuation Modestly Undervalued
View Full Analysis

What is Embla Medical hf Retained Earnings?

Embla Medical hf FRA:5IQ -1.34% 71 Retained Earnings is €769.9 Mil as of Jun. 2026. GuruFocus rates FRA:5IQ with a GF Score™ of 71/100 and a GF Value™ of €4.45 (Modestly Undervalued).

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Embla Medical hf's retained earnings for the quarter that ended in Jun. 2026 was €769.9 Mil.

Embla Medical hf's quarterly retained earnings increased from Dec. 2025 (€719.6 Mil) to Mar. 2026 (€741.9 Mil) and increased from Mar. 2026 (€741.9 Mil) to Jun. 2026 (€769.9 Mil).

Embla Medical hf's annual retained earnings increased from Dec. 2023 (€641.6 Mil) to Dec. 2024 (€725.0 Mil) but then declined from Dec. 2024 (€725.0 Mil) to Dec. 2025 (€719.6 Mil).


Embla Medical hf  (FRA:5IQ) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Embla Medical hf Retained Earnings Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf Retained Earnings Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 523.86 604.12 641.60 724.95 719.56

Embla Medical hf Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 688.96 697.09 719.56 741.92 769.92
FRA:5IQ
71GF Score
Embla Medical hf FRA:5IQ
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of €769.9 Mil mean?
Embla Medical hf (FRA:5IQ) has a Retained Earnings of €769.9 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's Retained Earnings too high?
Embla Medical hf's current Retained Earnings is €769.9 Mil. Overall, Embla Medical hf has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Retained Earnings compare to ABT and SYK?
Embla Medical hf's Retained Earnings of €769.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Retained Earnings is €769.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Based on GuruFocus' analysis, Embla Medical hf (FRA:5IQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.45, compared to a current price of €3.69 — trading 17.1% below its estimated fair value. The current Retained Earnings is €769.9 Mil. Embla Medical hf's overall GF Score™ is 71/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Embla Medical hf (FRA:5IQ), the current Retained Earnings is €769.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (FRA:5IQ) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of €3.69 is trading 17.1% below its estimated GF Value™ of €4.45. GuruFocus considers Embla Medical hf to be Modestly Undervalued.

Key valuation signals for FRA:5IQ:

  • Retained Earnings: €769.9 Mil
  • GF Value™: €4.45 vs. price of €3.69 (17.1% below fair value)
  • GF Score™: 71/100

No single metric tells the full story. See the FRA:5IQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Other Exchanges 0FIW:UKEMBLA:Denmark
Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
71GF Score

Get the complete analysis for FRA:5IQ

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.69
Price
€4.45
GF Value